• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心内膜心肌纤维化的生存决定因素。

Determinants of survival in endomyocardial fibrosis.

作者信息

Barretto A C, da Luz P L, de Oliveira S A, Stolf N A, Mady C, Bellotti G, Jatene A D, Pileggi F

机构信息

Divisão de Clínica, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brasil.

出版信息

Circulation. 1989 Sep;80(3 Pt 1):I177-82.

PMID:2766524
Abstract

This study describes the clinical course of 108 patients with endomyocardial fibrosis. There were 76 females and 32 males, with a mean age of 35 years. All patients underwent cardiac catheterization. The angiographic data show that 64 (59%) patients had biventricular involvement. From a clinical point of view, 91 (84%) were in New York Heart Association functional classes III and IV. According to the right and left ventricular intensity of fibrosis, the patients were classified as mild (40 [37%]), moderate (36 [33%]), or severe (32 [30%]) for the right ventricle and mild (19 [18%]), moderate (61 [56%]), or severe (28 [26%]) for the left ventricle. Tricuspid regurgitation was observed in 63 (58%) patients and mitral regurgitation in 65 (60%) patients. Fifty patients in functional classes III and IV underwent surgical treatment. Survival curves constructed according to functional classes showed better prognosis for those in classes I and II (p = 0.0452). Survival curves for patients in classes III and IV for clinical and surgical treatment showed a trend toward better results for the surgical group. Analysis of factors that may have influenced the course of endomyocardial fibrosis showed that biventricular involvement (moderate or severe), right ventricular fibrosis, and presence of tricuspid and mitral regurgitation were associated with greater mortality.

摘要

本研究描述了108例心内膜心肌纤维化患者的临床病程。其中女性76例,男性32例,平均年龄35岁。所有患者均接受了心导管检查。血管造影数据显示,64例(59%)患者有双心室受累。从临床角度看,91例(84%)患者属于纽约心脏协会心功能Ⅲ级和Ⅳ级。根据右心室和左心室纤维化的程度,患者被分为右心室轻度(40例[37%])、中度(36例[33%])或重度(32例[30%]),左心室轻度(19例[18%])、中度(61例[56%])或重度(28例[26%])。63例(58%)患者观察到三尖瓣反流,65例(60%)患者观察到二尖瓣反流。50例心功能Ⅲ级和Ⅳ级的患者接受了手术治疗。根据心功能分级绘制的生存曲线显示,Ⅰ级和Ⅱ级患者的预后较好(p = 0.0452)。心功能Ⅲ级和Ⅳ级患者临床治疗和手术治疗的生存曲线显示,手术组有更好结果的趋势。对可能影响心内膜心肌纤维化病程的因素分析表明,双心室受累(中度或重度)、右心室纤维化以及三尖瓣和二尖瓣反流的存在与更高的死亡率相关。

相似文献

1
Determinants of survival in endomyocardial fibrosis.心内膜心肌纤维化的生存决定因素。
Circulation. 1989 Sep;80(3 Pt 1):I177-82.
2
The surgical treatment of endomyocardial fibrosis: results in 55 patients.心内膜心肌纤维化的外科治疗:55例患者的治疗结果
Circulation. 1985 Sep;72(3 Pt 2):II274-9.
3
[Endomyocardial fibrosis. Course in patients undergoing clinical and surgical treatment].[心内膜心肌纤维化。接受临床及外科治疗患者的病程]
Arq Bras Cardiol. 1990 Oct;55(4):241-4.
4
Surgical treatment of endomyocardial fibrosis.心内膜心肌纤维化的外科治疗
J Thorac Cardiovasc Surg. 1983 May;85(5):738-45.
5
[The electrocardiogram in endomyocardial fibrosis].[心内膜心肌纤维化的心电图表现]
Arq Bras Cardiol. 1992 Oct;59(4):249-53.
6
Clinical meaning of ascites in patients with endomyocardial fibrosis.心内膜心肌纤维化患者腹水的临床意义。
Arq Bras Cardiol. 2002 Feb;78(2):196-9. doi: 10.1590/s0066-782x2002000200008.
7
M-mode echocardiographic features of endomyocardial fibrosis.心内膜心肌纤维化的M型超声心动图特征。
Br Heart J. 1982 Sep;48(3):222-8. doi: 10.1136/hrt.48.3.222.
8
Endomyocardial fibrosis.心内膜心肌纤维化
Acta Cardiol. 2011 Jun;66(3):375-7. doi: 10.2143/AC.66.3.2114140.
9
Endomyocardial fibrosis: report of 6 patients and review of the surgical literature.心内膜心肌纤维化:6例报告及外科文献综述
Ann Thorac Surg. 1980 Mar;29(3):243-8. doi: 10.1016/s0003-4975(10)61875-9.
10
Endomyocardial fibrosis in children.儿童心内膜心肌纤维化
Cardiol Young. 2001 Mar;11(2):205-9. doi: 10.1017/s1047951101000129.

引用本文的文献

1
Left ventricle endomyocardial fibrosis: a case report.左心室心肌纤维化:病例报告。
J Med Case Rep. 2023 Aug 12;17(1):361. doi: 10.1186/s13256-023-04056-z.
2
Intracardiac mass revealing a rare form of cardiomyopathy.心内肿块揭示一种罕见的心肌病。
BMJ Case Rep. 2022 Apr 21;15(4):e249037. doi: 10.1136/bcr-2022-249037.
3
Multimodality Imaging in Endomyocardial Fibrosis: An Unusual Etiology of Heart Failure.心内膜心肌纤维化的多模态成像:心力衰竭的一种罕见病因
CASE (Phila). 2021 Jul 8;5(5):301-304. doi: 10.1016/j.case.2021.06.002. eCollection 2021 Oct.
4
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation.一名非热带地区40岁女性心肌内膜纤维化病例报告:从初次就诊到紧急心脏移植
BMC Cardiovasc Disord. 2019 Dec 19;19(1):302. doi: 10.1186/s12872-019-1243-8.
5
Endomyocardial Fibrosis: an Update After 70 Years.心肌纤维化:70 年后的最新进展
Curr Cardiol Rep. 2019 Nov 22;21(11):148. doi: 10.1007/s11886-019-1244-3.
6
Endomyocardial fibrosis: past, present, and future.心内膜心肌纤维化:过去、现在与未来
Heart Fail Rev. 2020 Sep;25(5):725-730. doi: 10.1007/s10741-019-09848-4.
7
Characterization of Cardiopulmonary Exercise Testing Variables in Patients with Endomyocardial Fibrosis after Endocardial Resection.心内膜切除术后心内膜心肌纤维化患者心肺运动试验变量的特征分析
Arq Bras Cardiol. 2017 Dec;109(6):533-540. doi: 10.5935/abc.20170179.
8
A Development of Nucleic Chromatin Measurements as a New Prognostic Marker for Severe Chronic Heart Failure.作为严重慢性心力衰竭新预后标志物的核酸染色质测量方法的开发。
PLoS One. 2016 Feb 4;11(2):e0148209. doi: 10.1371/journal.pone.0148209. eCollection 2016.
9
Case 3/2015 - 53-year-old female with cardiogenic shock 12 years after surgical correction of endomyocardial fibrosis.病例3/2015 - 一名53岁女性,在心内膜心肌纤维化手术矫正12年后出现心源性休克。
Arq Bras Cardiol. 2015 Sep;105(3):309-15. doi: 10.5935/abc.20150119.
10
Heart failure in South America.南美洲的心力衰竭
Curr Cardiol Rev. 2013 May;9(2):147-56. doi: 10.2174/1573403x11309020007.